We showed an increase of CDKN2B‐AS1 expression in patients with head and neck squamous cell carcinoma (HNSCC) in The Cancer Genome Atlas (TCGA) dataset (Figure 1). This evidence concerns the gene CDKN2B and head and neck squamous cell carcinoma.